OrbiMed Advisors reports acquisition of $3.61 million in Electra Therapeutics common shares
ETRA•OrbiMed entities reported purchases of 472,571 Electra Therapeutics shares at prices ranging from $7.07 to $7.88 per share. Their reported indirect holdings totaled 7,357,741 shares after the purchases.
